[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

CMRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.00%

Insider Buying (Last 12 Months): $135,181.60

Insider Selling (Last 12 Months): $9,258.70

Chimerix Insider Trading History Chart

Chimerix Share Price & Price History

^$0.95

▼ -0.02 (-2.06%)

As of 11/28/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Chimerix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/10/2023	Fred A. Middleton	Director	Buy	2,705	$0.92	$2,488.60	82,705
9/28/2023	David Jakeman	VP	Sell	3,610	$0.99	$3,573.90	133,142
9/25/2023	Fred A. Middleton	Director	Buy	20,000	$0.98	$19,600.00	80,000
5/18/2023	Michael T Andriole	CFO	Buy	51,700	$1.14	$58,938.00	357,015
5/10/2023	Martha J Demski	Director	Buy	18,000	$1.11	$19,980.00	72,055
5/8/2023	Robert J. Meyer	Director	Buy	8,750	$1.14	$9,975.00	35,150
3/28/2023	Fred A. Middleton	Director	Buy	20,000	$1.21	$24,200.00	60,000
1/26/2023	David Jakeman	Insider	Sell	3,230	$1.76	$5,684.80	136,752
9/29/2022	David Jakeman	Insider	Sell	4,400	$1.86	$8,184.00	127,532
9/29/2022	Fred A. Middleton	Director	Buy	20,000	$1.86	$37,200.00	40,000
5/19/2022	Robert J. Meyer	Director	Buy	11,400	$2.06	$23,484.00	26,400
5/17/2022	Martha J Demski	Director	Buy	10,000	$1.61	$16,100.00	54,055
5/17/2022	Michael T Andriole	CFO	Buy	15,000	$1.71	$25,650.00	212,724
2/4/2022	David Jakeman	Insider	Sell	3,300	$5.56	$18,348.00
9/30/2021	David Jakeman	Insider	Sell	4,590	$6.19	$28,412.10
6/28/2021	Fred A. Middleton	Director	Buy	6,950	$7.83	$54,418.50	200,573
6/25/2021	Fred A. Middleton	Director	Buy	3,050	$7.78	$23,729.00	200,573
4/5/2021	David Jakeman	Insider	Sell	1,284	$9.68	$12,429.12
3/1/2021	Robert J. Meyer	Director	Buy	1,500	$9.80	$14,700.00	15,000
1/28/2021	David Jakeman	Insider	Sell	3,211	$8.61	$27,646.71	96,906

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Chimerix (NASDAQ:CMRX)

44.17% of Chimerix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Chimerix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2023	Jacobs Levy Equity Management Inc.	219,300	$0.21M	0.0%	-82.2%	0.247%
11/15/2023	RA Capital Management L.P.	6,501,624	$6.24M	0.1%	N/A	7.314%
11/15/2023	Armistice Capital LLC	2,872,000	$2.76M	0.0%	-9.6%	3.231%
11/15/2023	AQR Capital Management LLC	246,883	$0.24M	0.0%	-74.1%	0.278%
11/14/2023	Pale Fire Capital SE	98,896	$95K	0.0%	N/A	0.111%
11/13/2023	FMR LLC	71,031	$68K	0.0%	+436.2%	0.080%
11/9/2023	UBS Group AG	123,060	$0.12M	0.0%	-56.9%	0.138%
11/6/2023	Assenagon Asset Management S.A.	426,672	$0.41M	0.0%	+167.3%	0.482%
10/24/2023	Bank of New York Mellon Corp	591,697	$0.57M	0.0%	+190.0%	0.668%
10/11/2023	Vontobel Holding Ltd.	70,000	$67K	0.0%	+40.0%	0.079%
9/21/2023	Barclays PLC	834,544	$1.01M	0.0%	-4.9%	0.942%
8/15/2023	XTX Topco Ltd	316,293	$0.38M	0.1%	+35.5%	0.357%
8/15/2023	Y Intercept Hong Kong Ltd	93,836	$0.11M	0.0%	N/A	0.106%
8/15/2023	Goldman Sachs Group Inc.	1,431,405	$1.73M	0.0%	+13.9%	1.616%
8/15/2023	Caxton Associates LP	69,229	$84K	0.0%	-59.5%	0.078%
8/15/2023	Royal Bank of Canada	62,257	$75K	0.0%	+1,193.0%	0.070%
8/14/2023	Ergoteles LLC	55,666	$67K	0.0%	N/A	0.063%
8/14/2023	State of Wyoming	46,717	$57K	0.0%	-34.3%	0.053%
8/14/2023	Schonfeld Strategic Advisors LLC	30,100	$36K	0.0%	N/A	0.034%
8/14/2023	Shay Capital LLC	83,385	$0.10M	0.0%	N/A	0.094%
8/14/2023	State Street Corp	355,350	$0.43M	0.0%	-84.5%	0.401%
8/14/2023	WINTON GROUP Ltd	24,931	$30K	0.0%	N/A	0.028%
8/14/2023	Graham Capital Management L.P.	24,756	$30K	0.0%	N/A	0.028%
8/11/2023	Renaissance Technologies LLC	2,071,309	$2.51M	0.0%	+51.7%	2.338%
8/11/2023	BlackRock Inc.	1,146,046	$1.39M	0.0%	-76.5%	1.294%
8/11/2023	Geode Capital Management LLC	911,571	$1.10M	0.0%	-44.4%	1.029%
8/11/2023	Tejara Capital Ltd	372,640	$0.45M	0.2%	-5.0%	0.421%
8/11/2023	JPMorgan Chase & Co.	323,504	$0.39M	0.0%	-7.4%	0.365%
8/10/2023	Russell Investments Group Ltd.	32,870	$40K	0.0%	-71.1%	0.037%
8/10/2023	Charles Schwab Investment Management Inc.	37,732	$46K	0.0%	-83.6%	0.043%
8/9/2023	BNP Paribas Arbitrage SNC	538,215	$0.65M	0.0%	+517.1%	0.608%
8/8/2023	Monaco Asset Management SAM	4,377,674	$5.30M	1.5%	+83.5%	4.942%
8/7/2023	Acadian Asset Management LLC	2,041,883	$2.47M	0.0%	+2.6%	2.305%
8/3/2023	Barclays PLC	834,544	$1.01M	0.0%	-4.9%	0.942%
8/3/2023	Bank of New York Mellon Corp	204,059	$0.25M	0.0%	-52.8%	0.230%
7/31/2023	PVG Asset Management Corp	28,655	$35K	0.2%	-58.8%	0.032%
7/28/2023	Marquette Asset Management LLC	94,582	$0.11M	0.0%	N/A	0.107%
7/25/2023	Assenagon Asset Management S.A.	159,628	$0.19M	0.0%	-41.7%	0.180%
7/24/2023	Vontobel Holding Ltd.	50,000	$60K	0.0%	-52.4%	0.056%
5/18/2023	JPMorgan Chase & Co.	349,229	$0.44M	0.0%	-29.1%	0.394%
5/16/2023	State Street Corp	2,295,099	$2.89M	0.0%	-1.6%	2.591%
5/16/2023	Geode Capital Management LLC	1,638,302	$2.06M	0.0%	+4.1%	1.849%
5/16/2023	AQR Capital Management LLC	1,904,995	$2.40M	0.0%	+12.8%	2.150%
5/16/2023	Armistice Capital LLC	3,276,000	$4.13M	0.1%	+2.4%	3.698%
5/15/2023	Cubist Systematic Strategies LLC	44,467	$56K	0.0%	-30.2%	0.050%
5/15/2023	Public Employees Retirement System of Ohio	41,719	$53K	0.0%	-52.2%	0.047%
5/15/2023	Two Sigma Advisers LP	43,300	$55K	0.0%	-90.8%	0.049%
5/15/2023	Two Sigma Investments LP	44,298	$56K	0.0%	-92.9%	0.050%
5/15/2023	Deutsche Bank AG	56,308	$71K	0.0%	+33.8%	0.064%
5/15/2023	Rubric Capital Management LP	7,336,735	$9.24M	0.2%	-2.2%	8.282%
5/15/2023	XTX Topco Ltd	233,342	$0.29M	0.1%	+65.6%	0.263%
5/12/2023	Renaissance Technologies LLC	1,365,771	$1.72M	0.0%	+107.9%	1.542%
5/12/2023	BlackRock Inc.	4,885,409	$6.16M	0.0%	-2.9%	5.515%
5/12/2023	BNP Paribas Arbitrage SNC	87,216	$0.11M	0.0%	+81.4%	0.098%
5/12/2023	Prudential Financial Inc.	34,875	$44K	0.0%	-50.2%	0.039%
5/12/2023	UBS Group AG	195,088	$0.25M	0.0%	-24.6%	0.220%
5/12/2023	Yakira Capital Management Inc.	508,389	$0.64M	0.2%	N/A	0.574%
5/12/2023	Dimensional Fund Advisors LP	157,050	$0.20M	0.0%	-66.5%	0.177%
5/12/2023	Tejara Capital Ltd	392,359	$0.49M	0.3%	+20.0%	0.443%
5/11/2023	Acadian Asset Management LLC	1,989,699	$2.51M	0.0%	+90.9%	2.246%
5/11/2023	Rhumbline Advisers	116,165	$0.15M	0.0%	-7.2%	0.131%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	221,039	$0.28M	0.0%	-15.8%	0.250%
5/9/2023	Bank of New York Mellon Corp	431,955	$0.54M	0.0%	-6.1%	0.488%
5/9/2023	Russell Investments Group Ltd.	113,923	$0.14M	0.0%	-72.0%	0.129%
5/8/2023	Bailard Inc.	33,600	$42K	0.0%	N/A	0.038%
5/4/2023	Barclays PLC	877,233	$1.11M	0.0%	+29.4%	0.994%
4/28/2023	SG Americas Securities LLC	33,785	$43K	0.0%	+139.3%	0.038%
4/18/2023	Assenagon Asset Management S.A.	273,745	$0.35M	0.0%	+3.7%	0.310%
4/14/2023	Raymond James & Associates	64,200	$81K	0.0%	+39.4%	0.073%
4/13/2023	Allspring Global Investments Holdings LLC	128,976	$0.16M	0.0%	-65.6%	0.146%
3/23/2023	MetLife Investment Management LLC	44,657	$83K	0.0%	N/A	0.051%
2/16/2023	Alliancebernstein L.P.	154,900	$0.29M	0.0%	+7.8%	0.176%
2/16/2023	State of Wyoming	71,611	$0.13M	0.0%	N/A	0.081%
2/15/2023	Public Employees Retirement System of Ohio	87,253	$0.16M	0.0%	+168.5%	0.099%
2/15/2023	CI Private Wealth LLC	64,055	$0.12M	0.0%	N/A	0.073%
2/15/2023	MetLife Investment Management LLC	44,657	$83K	0.0%	N/A	0.051%
2/15/2023	Jane Street Group LLC	93,638	$0.17M	0.0%	-25.9%	0.106%
2/15/2023	Virtu Financial LLC	19,400	$36K	0.0%	-59.6%	0.022%
2/15/2023	Tejara Capital Ltd	326,832	$0.61M	0.4%	N/A	0.371%
2/15/2023	Millennium Management LLC	1,287,960	$2.40M	0.0%	-67.6%	1.463%
2/15/2023	Morgan Stanley	773,976	$1.44M	0.0%	-4.6%	0.879%
2/15/2023	Man Group plc	135,397	$0.25M	0.0%	+1,119.8%	0.154%
2/15/2023	AQR Capital Management LLC	1,688,437	$3.14M	0.0%	+819.0%	1.918%
2/15/2023	Armistice Capital LLC	3,200,000	$5.95M	0.1%	+16.1%	3.635%
2/14/2023	Alpine Global Management LLC	46,240	$86K	0.0%	+85.0%	0.053%
2/14/2023	Two Sigma Investments LP	621,948	$1.16M	0.0%	+15.0%	0.706%
2/13/2023	Charles Schwab Investment Management Inc.	229,784	$0.43M	0.0%	+3.3%	0.261%
2/13/2023	Deutsche Bank AG	42,068	$78K	0.0%	+33.5%	0.048%
2/13/2023	Barclays PLC	677,982	$1.26M	0.0%	+58.8%	0.770%
2/13/2023	Renaissance Technologies LLC	656,795	$1.22M	0.0%	+41.8%	0.746%
2/13/2023	The Manufacturers Life Insurance Company	33,517	$62K	0.0%	+107.3%	0.038%
2/13/2023	Credit Suisse AG	524,003	$0.98M	0.0%	-15.7%	0.595%
2/13/2023	Geode Capital Management LLC	1,573,052	$2.93M	0.0%	+1.6%	1.787%
2/13/2023	GSA Capital Partners LLP	19,989	$37K	0.0%	-94.1%	0.023%
2/13/2023	JPMorgan Chase & Co.	492,705	$0.92M	0.0%	+895.0%	0.560%
2/10/2023	Bank of America Corp DE	565,974	$1.05M	0.0%	+67.5%	0.643%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	262,404	$0.49M	0.0%	+522.0%	0.298%
2/10/2023	HRT Financial LP	62,510	$0.12M	0.0%	-75.2%	0.071%
2/9/2023	Dimensional Fund Advisors LP	468,943	$0.87M	0.0%	-24.6%	0.533%
2/9/2023	Principal Financial Group Inc.	29,762	$55K	0.0%	+41.0%	0.034%

Data available starting January 2016

Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases. Its pipeline products include ONC201 a program that is in Phase 2 clinical trial for treating tumors, which harbor the H3 K27M mutation in glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and CMX521, a nucleoside analog antiviral drug candidate for the treatment of SARS-CoV-2 (COVID-19) infection. The company has license agreement with SymBio Pharmaceuticals to develop and commercialize TEMBEXA for human diseases other than orthopoxviruses, including smallpox. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Today's Range

Now: $0.95

$0.95

$0.97

50 Day Range

MA: $0.98

$0.90

$1.06

52 Week Range

Now: $0.95

$0.88

$2.40

Volume

136,771 shs

Average Volume

792,220 shs

Market Capitalization

$84.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.14

Who are the company insiders with the largest holdings of Chimerix?: Chimerix's top insider investors include:
Michael T Andriole (CFO)
David Jakeman (Insider)
David Jakeman (VP)
Fred A Middleton (Director)
Martha J Demski (Director)
Robert J Meyer (Director)
Learn More about top insider investors at Chimerix.
Who are the major institutional investors of Chimerix?: Chimerix's top institutional investors include:
RA Capital Management L.P. — 7.31%
Armistice Capital LLC — 3.23%
Bank of New York Mellon Corp — 0.67%
Assenagon Asset Management S.A. — 0.48%
AQR Capital Management LLC — 0.28%
Jacobs Levy Equity Management Inc. — 0.25%
Learn More about top institutional investors of Chimerix stock.
Which institutional investors are selling Chimerix stock?: In the previous quarter, CMRX stock was sold by these institutional investors:
Jacobs Levy Equity Management Inc.
AQR Capital Management LLC
Armistice Capital LLC
UBS Group AG
During the previous year, company insiders that have sold Chimerix company stock include:
Michael T Andriole (CFO)
David Jakeman (Insider)
Learn More investors selling Chimerix stock.
Which institutional investors are buying Chimerix stock?: Within the last quarter, CMRX stock was bought by institutional investors including:
RA Capital Management L.P.
Bank of New York Mellon Corp
Assenagon Asset Management S.A.
Pale Fire Capital SE
FMR LLC
Vontobel Holding Ltd.
Group One Trading L.P.
Within the previous year, these company insiders have bought Chimerix stock:
Michael T Andriole (CFO)
David Jakeman (Insider)
David Jakeman (VP)
Fred A Middleton (Director)
Learn More investors buying Chimerix stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

CMRX Insider Trading

Chimerix Insider Trading History Chart

Chimerix Share Price & Price History

Chimerix Insider Trading History

SEC Filings (Institutional Ownership Changes) for Chimerix (NASDAQ:CMRX)

Institutional Buying and Selling by Quarter

Chimerix Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Chimerix?

Who are the major institutional investors of Chimerix?

Which institutional investors are selling Chimerix stock?

Which institutional investors are buying Chimerix stock?